- The Wall Street Journal•6 hours ago
Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment....
- Motley Fool•18 hours ago
Gilead Sciences might want to pay attention to Allergan's aggressive expansion of its NASH program.
- Market Realist•3 days ago
Novartis’s (NVS) Innovative Medicines segment includes products for therapeutic areas such as oncology, cardiometabolic, immunology, and dermatology.
NVS : Summary for Novartis AG - Yahoo Finance
Novartis AG (NVS)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||73.31 - 73.83|
|52 Week Range||66.93 - 83.58|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||26.21|
|Dividend & Yield||2.72 (3.71%)|
|1y Target Est||N/A|